You are here

obesity

Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands

Motley Fool

Mon, 02/3/25 - 11:55 am

Novo Nordisk commences fresh trials for CagriSema

Devdiscourse

Thu, 01/30/25 - 11:33 am

clinical trials

Versant invests again in obesity, this time backing Helicore Biopharma

BioPharma Dive

Tue, 01/28/25 - 10:44 am

Versant Ventures

Helicore Biopharma

Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial

Fierce Biotech

Tue, 01/28/25 - 10:17 am

Metsera eyes $289M IPO to fund phase 3 weight loss trial

Fierce Biotech

Mon, 01/27/25 - 11:32 am

Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%

Fierce Biotech

Fri, 01/24/25 - 11:47 am

clinical trials

After an obesity stumble, BioAge reconnects with its longevity pipeline

Pharma Voice

Wed, 01/22/25 - 11:20 am

Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial

Clinical Trials Arena

Tue, 01/21/25 - 11:27 am

Ascletis Pharma

clinical trials

Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy

Fierce Pharma

Fri, 01/17/25 - 11:34 am

clinical trials

JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance

Clinical Trials Arena

Tue, 01/14/25 - 09:54 am

Pfizer going 'all in' on obesity drug development, CEO Bourla says

Investing.com

Mon, 01/13/25 - 05:37 pm

2024 was a record year for obesity trials and 2025 is already poised to take over

Clinical Trials Arena

Mon, 01/13/25 - 11:07 am

clinical trials

Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial

Fierce Biotech

Mon, 01/13/25 - 11:01 am

Kailera Therapuetics

clinical trials

Jiangsu Hengrui Pharmaceuticals

5 questions facing pharma in 2025

BioPharma Dive

Fri, 01/10/25 - 11:47 am

Verdiva Bio raises $411m for obesity pipeline

Pharmaphorum

Thu, 01/9/25 - 11:06 am

Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes

Fierce Biotech

Wed, 01/8/25 - 11:23 am

artificial intelligence

3 trial readouts that could shake up the obesity market this year

Pharma Voice

Wed, 01/8/25 - 11:15 am

Skye Bioscience

clinical trials

FDA sets bar for obesity drug development as pipeline swells

First Word Pharma

Tue, 01/7/25 - 06:52 pm

Use of diabetes and anti-obesity drugs surges nationwide

Axios

Fri, 01/3/25 - 10:07 am

Merck joins obesity pill race with up to $2B Hansoh deal

BioSpace

Wed, 12/18/24 - 11:18 am

Pages